Sensipar (Amgen Inc)
Welcome to the PulseAid listing for the Sensipar drug offered from Amgen Inc. This Calcium-sensing Receptor Agonist [EPC],Increased Calcium-sensing Receptor Sensitivity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Amgen Inc |
NON-PROPRIETARY NAME: | cinacalcet hydrochloride |
SUBSTANCE NAME: | CINACALCET HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Calcium-sensing Receptor Agonist [EPC],Increased Calcium-sensing Receptor Sensitivity [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2004-04-04 |
END MARKETING DATE: | 0000-00-00 |
Sensipar HUMAN PRESCRIPTION DRUG Details:
Item Description | Sensipar from Amgen Inc |
LABELER NAME: | Amgen Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 30(mg/1) |
START MARKETING DATE: | 2004-04-04 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 55513-073_adef0d9b-f07c-434f-9217-ef2f45c91b91 |
PRODUCT NDC: | 55513-073 |
APPLICATION NUMBER: | NDA021688 |
Other CINACALCET HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: